Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice

Journal of Pathology

Volumn 210, Issue 3, 2006, Pages 325-333

  Cruz Topete, D ^a   Iwaki, T ^a   Ploplis, V A ^a   Castellino, F J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Afibrinogenaemia; Cougulopathy; Cytokines; Endotoxin; Inflammation; Neutrophil migration

Indexed keywords

ALBUMIN; ANTITHROMBIN; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ENDOTOXIN; FIBRIN; FIBRINOGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; THROMBIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BLOOD CLOTTING; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBRINOGEN DEFECT; GRAM NEGATIVE BACTERIUM; HEMOSTASIS; HISTOPATHOLOGY; INFLAMMATION; ISCHEMIA; LEUKOCYTE COUNT; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; THROMBOSIS; TIME; WILD TYPE;

AFIBRINOGENEMIA; ALBUMINS; ANIMALS; ANTITHROMBIN III; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CYTOKINES; E-SELECTIN; ENDOTHELIAL CELLS; FIBRIN; FIBRINOGEN; INFLAMMATION; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHILS; NITRIC OXIDE; PEPTIDE HYDROLASES; PEROXIDASE; TIME FACTORS;

EID: 33750529958     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2060     Document Type: Article

References (32)

1. Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, et al. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 1989;61:459-462.
2. Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M, et al. Depressed plasma activity of plasminogen or alpha 2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. Blood Coagul Fibrinolysis 2001;12:275-281.
3. Iba T, Kidokoro A, Fukunaga M, Sugiyama K, Sawada T, Kato H. Association between the severity of sepsis and the changes in hemostatic molecular markers and vascular endothelial damage markers. Shock 2005;23:25-29.
4. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med 2000;28:232-235.
5. Welty-Wolf KE, Carraway MS, Miller DL, Ortel TL, Ezban M, Ghio AJ. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001;164:1988-1996.
6. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001;167:2887-2894.
7. Kirschenbaum LA, McKevitt D, Rullan M, Reisbeck B, Fujii T, Astiz ME. Importance of platelets and fibrinogen in neutrophil-endothelial cell interactions in septic shock. Crit Care Med 2004;32:1904-1909.
8. Iwaki T, Cruz DT, Martin JA, Castellino FJ. A cardioprotective role for the endothelial protein C receptor in lipopolysaccharide-induced endotoxemia in the mouse. Blood 2005;105:2364-2371.
9. Ploplis VA, Wilberding J, McLennan L, Liang Z, Cornelissen I, DeFord ME, et al. A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Am J Pathol 2000;157:703-708.
10. Iwaki T, Sandoval-Cooper MJ, Paiva M, Kobayashi T, Ploplis VA, Castellino FJ. Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse. Am J Pathol 2002;160:1021-1024.
11. Daemen MA, Kurvers HA, Kitslaar PJ, Slaaf DW, Bullens PH, Van den Wildenberg FA. Neurogenic inflammation in an animal model of neuropathic pain. Neurol Res 1998;20:41-45.
12. Ganopolsky JG, Castellino FJ. A protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture model. Am J Pathol 2004;165:1433-1446.
13. Mosesson MW. Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003;89:9-12.
14. Qi J, Goralnick S, Kreutzer DL. Fibrin regulation of interteukin-8 gene expression in human vascular endothelial cells. Blood 1997;90:3595-3602.
15. Qi J, Kreutzer DL. Fibrin activation of vascular endothelial cells. Induction of IL-8 expression. J Immunol 1995;155:867-876.
16. Qi J, Kreutzer DL, Piela-Smith TH. Fibrin induction of ICAM-1 expression in human vascular endothelial cells. J Immunol 1997;158:1880-1886.
17. Flick MJ, Du X, Witte DP, Jirouskova M, Soloviev DA, Busuttil SJ, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004;113:1596-1606.
18. Harter L, Mica L, Stocker R, Trentz O, Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 2004;22:403-409.
19. Iwaki T, Castellino FJ. Maternal fibrinogen is necessary for embryonic development. Curr Drug Targets 2005;6:535-539.
20. Iwaki T, Sandoval-Cooper MJ, Brechmann M, Ploplis VA, Castellino FJ. A fibrinogen deficiency accelerates the initiation of LDL-cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically-predisposed mice. Blood 2006;107:3883-3891.
21. Chevrel G, Granet C, Miossec P. Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 2005;64:1257-1262.
22. Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP. Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J Immunol 2005;175:7530-7535.
23. Ha E, Jung KH, Choe BK, Bae JH, Shin DH, Yim SV, et al. Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci Lett 2006;397:185-189.
24. Weber TJ, Smallwood HS, Kathmann LE, Markillie LM, Squier TC, Thrall BD. Functional link between TNF biosynthesis and CaM-dependent activation of inducible nitric oxide synthase in RAW 264.7 macrophages. Am J Physiol Cell Physiol 2006;290:C1512-Cl520.
25. Pfeilschifter J. Nitric oxide triggers the expression of proinflammatory and protective gene products in mesangial cells and the inflamed glomerulus. Nephrol Dial Transplant 2002;17:347-348.
26. Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, etal. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nature Med 2001;7:1123-1127.
27. Taylor KE, Giddings JC, van den Berg CW. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 2005;25:1225-1230.
28. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 1996;156:1963-1972.
29. Call DR, Nemzek JA, Ebong SJ, Bolgos GR, Newcomb DE, Wollenberg GK, et al. Differential local and systemic regulation of the murine chemokines KC and MIP2. Shock 2001;15:278-284.
30. Yokoi K, Mukaida N, Harada A, Watanabe Y, Matsushima K. Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by a monoclonal antibody to IL-8. Lab Invest 1997;76:375-384.
31. Skidgel RA, Gao XP, Brovkovych V, Rahman A, Jho D, Predescu S. Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. Immunol 2002;169:2093-2101.
32. Tsujimoto H, Ono S, Majima T, Kawarabayashi N, Takayama E, Kinoshita M, et al. Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 2005;23:39-44.